Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: antiviral

February 17, 2023 CD as API / Drug delivery / Pharma applications

The Role of Cyclodextrins in COVID-19 Therapy-A Literature Review

Coronavirus disease-19 (COVID-19) emerged in December 2019 and quickly spread, giving rise to a pandemic crisis. Therefore, it triggered tireless

Continue reading

microscopic shot of a virus
January 24, 2023 CD as API / Life sciences / Pharma applications

Patent application on reduction of envelope viral particle number in a composition containing cyclodextrin

US patent application US2022409653 entitled “METHOD FOR PREVENTING ENTRY AND REPLICATION OF ENVELOPED VIRUSES” descibes a method for the reduction

Continue reading

December 19, 2022 CD as API / Pharma applications

HPβ-CD as affordable antiviral to treat coronavirus infection

In a recent study posted to the bioRxiv* preprint server, researchers identified β-cyclodextrins (β-CDs) as a safe and cost-effective drug

Continue reading

December 8, 2021 CD derivatives / Pharma applications

Gilead Statement on Veklury® (Remdesivir) and the SARS-CoV-2 Omicron Variant

Gilead has conducted an analysis of genetic information currently available for the Omicron variant and found no additional prevalent mutations

Continue reading

March 18, 2021 CD as API / CD derivatives / Pharma applications

First results on cyclodextrins against dengue fever from CycloLab

In May, 2020, CycloLab announced a collaboration, where University of California, Berkeley, Excivion and CycloLab teamed-up to evaluate the antiviral

Continue reading

October 2, 2020 Drug delivery / Pharma applications

UofA lab uncovers new mechanism of action against SARS-CoV-2 by antiviral drug remdesivir

News Release on 23-Sep-2020 on Eurokalert Researchers at the University of Alberta have discovered a novel, second mechanism of action

Continue reading

August 10, 2020 Pharma applications

Pfizer agrees to manufacture Gilead’s coronavirus drug remdesivir

Pfizer has agreed to manufacture and supply Gilead Sciences’ antiviral drug remdesivir, the pharmaceutical giant announced Friday.  The multiyear agreement will support efforts to

Continue reading

July 17, 2020 Pharma applications

Wacker on cyclodextrins in the COVID fight

The world’s largest cyclodextrin producer, Wacker Chemie has recently published a press release on cyclodextrins and their role in the

Continue reading

June 8, 2020 CD as API / Pharma applications

ALL EYES ON GILEAD

Bloombergs Businessweek published the story on how Gilead scineces prepared for the recently obtained emergency approval of the antiviral drug

Continue reading

May 13, 2020 CD derivatives / Pharma applications

Voluntary Licensing Agreements for Remdesivir

Gilead has signed non-exclusive voluntary licensing agreements with five generic pharmaceutical manufacturers based in India and Pakistan to further expand

Continue reading

Posts navigation

1 2 Next Posts»

Recent Posts

  • Antifungal pentachloronitrobenzene/hydroxypropyl-beta-cyclodextrin inclusion complex nanofibers by electrospinning with no polymer
  • Special issue of EuroCD2023 is open for submission
  • Ensembles of carboxymethyl cyclodextrins on cationic liposomes as highly efficient nanocontainers for the delivery of hydrophobic compounds
  • Exploring Isomerism in Isolated Cyclodextrin Oligomers through Trapped Ion Mobility Mass Spectrometry
  • Avoiding Interferences in Advance: Cyclodextrin Polymers to Enhance Selectivity in Extraction of Organic Micropollutants for Carbon Isotope Analysis

Tags

alpha-CD Alzheimer disease Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (15)
  • Analysis (37)
  • CD as API (214)
  • CD derivatives (268)
  • Cosmetics and toilettry (22)
  • Diagnosis (1)
  • Drug delivery (458)
  • E-ducation (56)
  • Environmental (80)
  • Events (163)
  • Food (128)
  • Gene delivery (10)
  • In Hungarian (4)
  • Life sciences (19)
  • Non-pharma applications (228)
  • Other industrial use (68)
  • Pharma applications (727)
  • Supramolecular systems (27)
  • Uncategorized (47)

Top Posts

  • Special issue of EuroCD2023 is open for submission
  • Lanosterol eye drops for cataract treatment
  • Avoiding Interferences in Advance: Cyclodextrin Polymers to Enhance Selectivity in Extraction of Organic Micropollutants for Carbon Isotope Analysis
  • 7th European Cyclodextrin Conference
  • Ensembles of carboxymethyl cyclodextrins on cationic liposomes as highly efficient nanocontainers for the delivery of hydrophobic compounds
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Ashland webinar — the magic rings: how cyclodextrins can enable drug development
  • Antifungal pentachloronitrobenzene/hydroxypropyl-beta-cyclodextrin inclusion complex nanofibers by electrospinning with no polymer
  • Website of EuroCD Conference is open
  • Synthesis and potential applications of cyclodextrin-based metal–organic frameworks: a review

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 551 other subscribers
 

Loading Comments...